Write an FICM OSCE station question for a 71‑year‑old male ICU patient with a large‑volume intracerebral haemorrhage who is intubated, sedated, and has liquid stools, requiring a fecal management system, covering indications, contraindications, insertion technique, post‑insertion care, complications, and weaning plan.

FICM OSCE Station: Fecal Management System in ICU

Clinical Scenario

You are the ICU registrar reviewing a 71-year-old male patient admitted 24 hours ago with a large-volume intracerebral hemorrhage. He is intubated, sedated (GCS 3T), and has developed profuse liquid stools (>500mL every 2-3 hours). The nursing staff report difficulty managing fecal incontinence, with concerns about skin breakdown and contamination of central lines. The consultant asks you to assess the patient for a fecal management system (FMS).

---

Candidate Instructions (10 minutes)

You will be assessed on your ability to:

1. Identify appropriate indications for FMS insertion
2. Screen for contraindications and safety concerns
3. Describe the insertion technique step-by-step
4. Outline post-insertion monitoring and complications
5. Formulate a weaning plan

The examiner will ask you specific questions about each domain.

---

Examiner Mark Scheme

Domain 1: Indications (2 marks)

Candidate should identify that FMS is indicated for:

• High-volume liquid stool in immobilized/sedated ICU patient 1
• Prevention of pressure ulcer development and wound contamination 1, 2
• Reduction of nursing workload and infection risk in fecal incontinence 1
• Key point: FMS prevents complications (skin breakdown, catheter contamination) rather than treating the underlying diarrhea 3

Award 1 mark for 2-3 indications, 2 marks for all key points

---

Domain 2: Contraindications & Safety Assessment (3 marks)

Candidate must actively exclude:

Absolute contraindications:

• Recent colorectal surgery (<8 weeks)
• Active rectal/colonic bleeding or known mucosal injury
• Severe neutropenia or immunosuppression
• Rectal/colonic tumor or stricture
• Fecal impaction (must be cleared first)

Relative contraindications requiring risk-benefit analysis:

• Coagulopathy (INR >2.0, platelets <50,000) - correct before insertion
• Recent myocardial infarction (<2 weeks) - vagal stimulation risk
• Inflammatory bowel disease in active flare

Safety checks:

• Digital rectal examination to exclude impaction/masses 3
• Review coagulation profile and platelet count
• Assess for hemodynamic instability

Award 1 mark for identifying 2-3 absolute contraindications, 2 marks for comprehensive list, 3 marks for including safety checks

---

Domain 3: Insertion Technique (4 marks)

Step-by-step procedure:

1. Preparation:

   • Position patient left lateral or supine
   • Ensure adequate sedation/analgesia
   • Gather equipment: FMS kit, lubricant, 50mL syringe, collection bag
   • Perform digital rectal exam to clear stool and assess sphincter tone

2. Insertion:

   • Lubricate catheter tip generously
   • Insert gently 6-8cm beyond anal sphincter (typically 10-15cm total depth)
   • Critical: Avoid forceful insertion - risk of rectal perforation 2
   • Inflate retention balloon with manufacturer-specified volume (typically 40-45mL water, NOT saline)
   • Gently retract until balloon seats against rectal wall

3. Securing:

   • Connect to low-pressure drainage bag (gravity drainage, NOT suction)
   • Secure tubing to prevent tension on catheter
   • Document insertion depth and balloon volume

4. Confirmation:

   • Verify drainage of liquid stool
   • Check balloon position does not obstruct drainage holes

Award 1 mark for basic steps, 2 marks for correct depth/balloon volume, 3 marks for safety emphasis, 4 marks for complete technique

---

Domain 4: Post-Insertion Care & Complications (4 marks)

Monitoring requirements:

Daily assessments:

• Inspect perianal skin for pressure injury (device should be repositioned every 24-48 hours by deflating/reinflating balloon)
• Monitor drainage volume and character
• Check for rectal bleeding (small amount of blood-tinged mucus is common initially)
• Verify balloon integrity and position

Maximum duration: 29 days per manufacturer guidelines, though recommend removal/replacement every 7-14 days to minimize mucosal injury risk 2, 3

Major complications to recognize:

1. Rectal bleeding (most serious - occurs in ~3% of cases, 0.5 events per 100 device-days) 2:

   • Mucosal ulceration from pressure necrosis
   • Action: Remove device immediately, assess hemodynamic status, consider sigmoidoscopy if bleeding significant

2. Rectal perforation (rare but catastrophic):

   • Presents with peritonitis, pneumoperitoneum
   • Action: Surgical emergency - immediate removal, broad-spectrum antibiotics, surgical consultation

3. Device malfunction:

   • Balloon deflation (check and reinflate)
   • Catheter blockage (irrigate gently with 30-50mL warm water)
   • Leakage around device (reposition or upsize if available)

4. Vagal stimulation: Bradycardia during insertion/manipulation

Red flags requiring immediate removal:

• Frank rectal bleeding (>50mL)
• Severe abdominal pain or distension
• Signs of perforation (fever, peritonism, surgical emphysema)

Award 1 mark for basic monitoring, 2 marks for duration limits, 3 marks for identifying major complications, 4 marks for management of complications

---

Domain 5: Weaning Plan (2 marks)

Criteria for removal:

1. Stool consistency improves to formed/semi-formed (Bristol type 3-4)
2. Frequency decreases to <3 bowel movements per 24 hours
3. Underlying cause treated (e.g., Clostridioides difficile infection resolved, enteral feeding tolerance improved)
4. Patient mobility improving or sedation weaning allows for bedpan/commode use

Removal technique:

• Deflate balloon completely
• Remove gently during expiration
• Inspect device for integrity
• Monitor for post-removal bleeding (first 2 hours)

Post-removal care:

• Barrier cream to perianal skin
• Continue monitoring stool pattern
• Consider oral anti-diarrheal agents (loperamide) if appropriate 4

Award 1 mark for basic weaning criteria, 2 marks for complete plan including post-removal care

---

Key Teaching Points for Examiners

Common pitfalls to probe:

1. Overinflating balloon - causes mucosal ischemia and bleeding
2. Leaving device in situ >14 days without reassessment - increases complication risk 2
3. Inserting with fecal impaction present - device will not function and increases perforation risk
4. Applying suction to drainage - causes mucosal trauma
5. Ignoring coagulopathy - significantly increases bleeding risk

Critical safety message: FMS are temporary adjuncts (median duration 5 days 2), not definitive management. The underlying cause of diarrhea must be investigated and treated concurrently (consider C. difficile testing, medication review, enteral feeding intolerance) 5.

Mortality context: Patients requiring FMS have significantly higher ICU mortality (15% vs 7.7% in general ICU population) and longer stays (mean 14 vs 2.8 days) 2, reflecting severity of illness rather than device-related harm.

---

Model Answer Summary

For this 71-year-old with ICH and profuse liquid stools, FMS insertion is appropriate to prevent skin breakdown and line contamination 1. After excluding contraindications (perform DRE, check coagulation), insert to 10-15cm depth with 40-45mL balloon inflation, using gravity drainage only. Monitor daily for rectal bleeding (the most significant complication at 3% incidence 2), reposition every 24-48 hours, and plan removal within 7-14 days once stool consistency improves. Simultaneously investigate and treat the underlying cause of diarrhea rather than relying on FMS as definitive therapy 3, 5.